A plasma factor inhibiting lymphocyte reactivity in urologic cancer patients.
D000230:Adenocarcinoma / Q000276:immunology; D000704:Analysis of Variance; D002478:Cells, Cultured; D005260:Female; D006801:Humans; D007106:Immune Sera; D007111:Immunity, Cellular; D007122:Immunoelectrophoresis; D008297:Male; D011471:Prostatic Neoplasms / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology*; D013936:Thymidine; D014316:Tritium; D001749:Urinary Bladder Neoplasms / Q000276:immunology; D014565:Urogenital Neoplasms / Q000276:immunology*
D007106:Immune Sera; D014316:Tritium; D013936:Thymidine